Tarsus Pharmaceuticals (TARS) Shares Outstanding (2019 - 2026)

Tarsus Pharmaceuticals' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $43.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 2.44% year-over-year to $43.0 million; the TTM figure through Mar 2026 stood at $43.0 million (up 2.44% YoY), while the FY2025 annual figure was $42.6 million, up 10.96% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $43.0 million, up from $42.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $43.0 million in Q1 2026, with the low at $20.7 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $37.7 million (2024), against an average of $34.5 million.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) gained 0.13% in 2022, then jumped 41.38% in 2024.
• Tarsus Pharmaceuticals' Shares Outstanding (Entity) stood at $26.7 million in 2022, then climbed by 28.0% to $34.2 million in 2023, then rose by 12.1% to $38.3 million in 2024, then rose by 10.96% to $42.6 million in 2025, then gained by 1.1% to $43.0 million in 2026.
• Business Quant data shows TARS's Shares Outstanding (Entity) at $43.0 million in Q1 2026, $42.6 million in Q4 2025, and $42.4 million in Q3 2025.